VC firm
BioVentures Investors
Also known as BioVentures Investors IV Limited Partnership, BIOVENTURES INVESTORS MEDTECH GROWTH, BIOVENTURES INVESTORS MEDTECH GROWTH CAPITAL, LP
- Investor type
- VC
- Investing status
- Activeas of 2026-09-21Source (opens in a new tab)
- Headquarters
- WELLESLEY, MA, United States
- Assets under management
- $303MForm ADV private fund GAV, as of 2026-03-26Source (opens in a new tab)
- Latest fund size
- $30.1MSEC amount sold, as of 2015-01-30Source (opens in a new tab)
- Funds
- 6
- Check size
- $5M to $25MSource (opens in a new tab)
- Legal name
- BIOVENTURES II MANAGEMENT CORPORATION
Claim, correct or request removal
Record updated 29 September 2026
About
We are committed to the innovators who are changing the practice of medicine. BioVentures MedTech Funds invests in companies that are developing today’s leading-edge medical technologies. Together, we create the dynamic solutions that improve healthcare outcomes worldwide.
Investment approach
- Thesis
- We believe that technology is key to finding new ways to create value and to increase efficiency and quality in healthcare delivery.Source (opens in a new tab)
- Leads rounds
- Yes
- Lead policy
- Most often, we lead financing rounds and work to ensure companies are appropriately financed to achieve clear inflection milestones necessary for success.
- Takes board seats
- Yes
- Board policy
- BioVentures MedTech Funds will typically be represented on the board, and whichever member or members of our team are best suited to the investment and the company will play an active role of support and guidance.
- Investing status notes
- WE INVEST IN EMERGING & GROWTH STAGE MEDTECH COMPANIES
Funds
- BIOVENTURES INVESTORS MEDTECH GROWTH CAPITAL, LP
- $204MVintage 2020, SPV, SEC amount sold
- BioVentures Investors IV Limited Partnership
- $30.1MVintage 2015, Main fund, SEC amount sold
- BIOVENTURES INVESTORS LIMITED PARTNERSHIP II
- Main fund
- BIOVENTURES INVESTORS (OFFSHORE) III LP
- Main fund
- BIOVENTURES INVESTORS (OFFSHORE) IV LIMITED PARTNERSHIP
- Main fund
- BIOVENTURES INVESTORS III LIMITED PARTNERSHIP
- Main fund
SEC registration
- Registered adviser
- BIOVENTURES II MANAGEMENT CORPORATION
- CRD number
- 161520 (opens in a new tab)
- SEC file number
- 802-74905
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $303Mas of 2026-03-26
- Private funds reported
- 6
- Principal office
- WESTBOROUGH, MA, United States
- SEC CIK
- 1632398, 1835848
Loading relationship preview